about
P1343
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionGrowth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptorSTEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumorsAndrogen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediatorSurface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene familyTissue specific and androgen-regulated expression of human prostate-specific transglutaminaseThe program of androgen-responsive genes in neoplastic prostate epithelium.Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA displayNon-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsSteroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferationVariations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissuesExpression and function of the human androgen-responsive gene ADI1 in prostate cancerHigh expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostateClinical and experimental progression of a new model of human prostate cancer and therapeutic approachTranscriptional programs activated by exposure of human prostate cancer cells to androgenApplication of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progressionInvestigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerChemoaffinity capture of pre-targeted prostate cancer cells with magnetic beadsThe many faces of neuroendocrine differentiation in prostate cancer progressionDifferential effects of tissue culture coating substrates on prostate cancer cell adherence, morphology and behaviorSegmentation of Image Data from Complex Organotypic 3D Models of Cancer Tissues with Markov Random Fields.GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cellsUnique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsAndrogens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathwaysRole for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cellsDoxycycline alters metabolism and proliferation of human cell linesChemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils of plants from Burkina FasoComparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate CellsImmortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer Research4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.In vivo photoacoustic lifetime imaging of tumor hypoxia in small animals.Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancerMechanosensitive Ca(2+) permeant cation channels in human prostate tumor cells.Nonsteroidal androgen receptor ligands: versatile syntheses and biological data.FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.Targeting HOX transcription factors in prostate cancer
P2860
Q21129293-0CD58CE1-EE65-477F-AC41-7CB5B4B5F758Q21284425-A03B23A9-50D5-4477-80F1-A4094B816896Q22010908-EB5A0024-17D0-42DC-9547-2DB8667B9033Q24290153-50FB537C-EDEB-4691-9C57-6E47601F8227Q24309519-3CE181FD-DF7A-4F7A-BA3F-002F9A4F7BD8Q24534258-EA50DC6D-2006-4A6B-982F-AFB2953CAD3CQ24535711-AE8F832C-91DE-4D2A-B6F5-89BBD2C64499Q24564122-FEBC3A8B-BFEA-4FC1-BE6A-B09EE18EC2FDQ24622202-572811B2-75EF-403C-9C7E-7CE76583C946Q24631073-873D63CF-44BF-4195-850F-4675B0CE8214Q24649615-9230EE68-263B-47C9-866C-6FE82E933781Q24678603-661F9DF5-41AD-4FFD-970C-988A7A74B63EQ24684793-30038848-0BEE-499C-B789-F956BADD2E23Q24685731-96F3D288-A58A-4353-B511-C65553F245ABQ24802648-13F27AF9-C913-4047-94A7-97BB249E914FQ24813698-118632C8-B003-47D3-8BD5-E205A40FEFB5Q24815816-D4F4D824-6E8B-41D7-9A23-F845415CF656Q24817218-798746E4-2D21-4298-87EE-E269CB162F40Q26739708-C688DF20-B2D8-4D68-9401-B1510EA234FCQ26777310-A27A48C7-AA17-4376-A44D-1E401D3C4778Q26861322-0DA43DFB-C255-4247-ABF7-3E1F3B44D523Q26992049-F54488AB-2B05-4FB3-9F70-C9FC18739F05Q27331332-03212126-3288-4C3F-BC27-349EB064905AQ27338443-1048B473-9066-4FAA-A593-57CF79021541Q28363395-BB4F1844-050B-4E80-A067-BF14EB928914Q28391298-A5E2EB05-500D-4BC0-9813-C9FBC6859CD7Q28397032-E10E06E2-4572-4DE4-BAF5-1BDB76E4FC26Q28472519-7B25D67C-A5E4-48E1-947F-4AA0AE9E531AQ28533505-A88474FC-660A-4A63-99F9-BE85B5F6B139Q28541371-01ABBF65-027D-4AE7-8F9A-535D631EE743Q28547040-ECD22953-980F-49AB-96A0-3C404AC51BD0Q30085830-B578D5DA-76F4-4F2D-8038-3EEF8CDC2835Q30414471-9C5E7207-7D7D-4E30-BA26-0669D27E81D3Q30434454-68012061-3FF6-4C91-93C4-61D5AC4DA3A8Q30438661-F890F212-250F-4084-9F36-1C80581C0FA7Q30440162-B4A7A700-749F-4AD3-81C3-14A216EF5DFEQ30528750-990D7B49-28B9-4516-8E90-C4A5B557D970Q30829176-BB9E8979-631E-48BC-A64E-C9A07798E7EAQ31083556-D00394EC-7483-4DC0-BC7D-DE467D1A4F82Q31150248-663D467A-315F-4B3D-9EC1-BA6549C2180E
P2860
description
1983 nî lūn-bûn
@nan
1983 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
LNCaP model of human prostatic carcinoma.
@ast
LNCaP model of human prostatic carcinoma.
@en
LNCaP model of human prostatic carcinoma.
@nl
type
label
LNCaP model of human prostatic carcinoma.
@ast
LNCaP model of human prostatic carcinoma.
@en
LNCaP model of human prostatic carcinoma.
@nl
prefLabel
LNCaP model of human prostatic carcinoma.
@ast
LNCaP model of human prostatic carcinoma.
@en
LNCaP model of human prostatic carcinoma.
@nl
P2093
P1433
P1476
LNCaP model of human prostatic carcinoma
@en
P2093
Horoszewicz JS
Kawinski E
Rosenthal H
P304
P407
P4510
P577
1983-04-01T00:00:00Z